Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of neuronal nicotinic receptors (NNR) Therapeutics for the treatment of multiple diseases and disorders of the central nervous system. The Company has clinical-stage product candidates for... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

Tranzyme Pharma is developing a number of mechanism-based therapeutics for the treatment of gastrointestinal (GI) and metabolic diseases. GI and metabolic diseases are characterized by large, underserved markets with few or poorly performing drugs for most indications. The Company is... more

ExonHit Therapeutics is a worldleading company in developing novel pharmaceuticals and diagnostics from its unique understanding of alternative RNA splicing, the process by which a single gene can lead to several proteins. The company's proprietary gene profiling technology DATASÔ, allows... more

Lorus Therapeutics Inc. (Lorus) is a life sciences company focused on the discovery, research and development of anticancer therapies. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to an... more

GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more

MethylGene Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for cancer. As of December 31, 2007, the Company is running multiple Phase I, Phase I/II, and Phase II clinical trials with its compound MGCD0103, an HDAC oncology... more

BioVex is a biotechnology company focused on the development of novel biologics for the treatment of cancer and infectious disease. Our lead product for the treatment of cancer is OncoVEXGM-CSF. OncoVEXGM-CSF is in Phase II clinical development and is currently being tested in clinical... more

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for... more

Sunesis Pharmaceuticals, Inc. (Sunesis) is a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of small molecule therapeutics for use in oncology and other diseases. As of December 31, 2007, the Company was advancing three... more

Pro-Pharmaceuticals, Inc. is a development stage company engaged in the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds for advanced treatment of cancer, liver, microbial and inflammatory diseases. The Company focuses on the development of a... more

Novavax, Inc. is a clinical stage vaccine company committed to leading the global fight against infectious diseases by creating novel, highly potent vaccines that are safer and more effective than current preventive options.

Peregrine Pharmaceuticals, Inc. (Peregrine) is a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its compounds bavituximab and Cotara... more

Predix is a privately held, clinical stage drug development company that uses a proprietary discovery and lead optimization system to develop drugs for G-protein coupled receptor (GPCR) and ion channel targets. Over the past two and a half years, the company has discovered several novel... more

Avalon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of first-in-class cancer therapeutics. Its lead product candidate, AVN944, an inosine monophosphate dehydrogenase (IMPDH) inhibitor, is in Phase II clinical development.... more

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company that discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases. The Company's research focuses on intracellular signalling pathways and... more

Sirna Therapeutics is a clinical-stage biotechnology company developing RNAi-based therapies for serious diseases and conditions, including age- related macular degeneration (AMD), hepatitis B and C, dermatology, asthma, Huntington's Disease, diabetes and oncology. Sirna Therapeutics has... more

ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s lead products, which are in clinical-stage testing, consist of ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an... more

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in... more

TOPIGEN is developing several new classes of drugs and is actively progressing two drug candidates in Phase II trials for COPD and asthma. These drugs are uniquely focused on inhibiting multiple inflammation targets underlying the chronic pulmonary diseases. TOPIGEN also has a number of... more

Celsion Corporation is a biotechnology company focused on developing drugs for the treatment of various cancer indications. The first of these development projects involves ThermoDox, a heat activated liposome containing doxorubicin. The Company plans to develop ThermoDox for multiple... more

Demegen develops natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's lead products address important unmet medical needs. Applications under development include dermatological, vaginal, respiratory,... more

ViaCell, Inc., a wholly owned subsidiary of PerkinElmer, is dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible... more

Cytochroma Inc. is a development stage specialty pharmaceutical company focused on the treatment and prevention of disorders related to Vitamin D insufficiency. The Company has a portfolio of therapeutics with lower development risk for the indications of Vitamin D insufficiency and for... more

AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (when necessary) and license these products to other pharmaceutical companies for worldwide commercialization. ... more

Pharmasset, Inc. (Pharmasset) is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. The Company's primary focus is on the development of oral therapeutics for the treatment of human immunodeficiency virus... more

Nastech is a clinical stage biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on our proprietary molecular biology-based drug delivery technologies and our proprietary ribonucleic acid interference technology. Nastech and... more

CEL-SCI Corporation is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day. Multikine is multi-targeted, it is the cancer immunotherapy that both kills cancer... more

At ActivBiotics, we are dedicated to achieving success through leadership and the unrelenting pursuit of scientific breakthrough. Our greatest asset is our people, and we are bringing together the brightest and most talented scientific professionals to the ActivBiotics team. If you are an... more

Inhibitex, Inc. is a biopharmaceutical company focused on the development of differentiated anti-infective products. It pursues pre-clinical or clinical-stage antiviral development programs via in-licensing or acquisition. On September 19, 2007, the Company completed the acquisition of... more

SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. SGX's oncology pipeline includes drug candidates from its enabling, proprietary FASTÔ drug discovery platform, such... more

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

We are a clinical-stage biopharmaceutical company that uses our patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a novel technology that genetically transforms the... more

Immusol is a private biotechnology company located in San Diego, California. The company currently employs approximately 50 employees, 90% of whom are focused on Research and Development. Immusol has built a management team with considerable combined experience in drug discovery and... more

Caprion offers its employees a dynamic and stimulating work environment, encouraging continuous innovation and the sharing of knowledge and ideas. We offer a comprehensive compensation package, including a competitive salary, participation in an employee stock option plan, a group... more

AlphaVax is developing a new vaccine technology with broad applications against infectious disease, cancer and biodefense threats which has the potential to redefine vaccines and the role they play in medicine. AlphaVax uses a specialized viral vector system to make alphavirus replicon... more

Bionovo, Inc. (Bionovo) is a clinical stage drug discovery and development company focusing on women’s health and cancer. The Company’s lead drug candidate, MF101, represents a class of receptor sub-type selective estrogen receptor modulator for the treatment of vasomotor symptoms of... more

NovaCardia, Inc. is a clinical-stage pharmaceutical company focused on developing drugs to treat major cardiovascular diseases that are underserved by existing therapies.

Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developed. We seamlessly integrate our capabilities in drug discovery, medicinal chemistry and translational medicine with proprietary automated technologies to discover and develop high... more

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. In July 2007, the Company initiated a Phase I clinical trial in the United Kingdom with its lead candidate in clinical development, ATHX-105, for the treatment of... more

Diosynth Biotechnology specializes in the cGMP production of recombinant proteins/peptides for therapeutic and vaccine applications. Our primary customers are companies developing and marketing these exciting biological products. These range from multinational pharmaceutical companies to... more

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first acquired involved loading 1 liter... more

D-Pharm (www.dpharm.com) is a biopharmaceutical company pioneering the development of lipid-like therapeutics and has generated a rich product pipeline from its drug targeting and discovery technologies, Regulated Activation of Prodrugs (D-RAPTM) and Membrane Active Chelators (MAC). The... more

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate... more

Corautus Genetics Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapy products for the treatment of cardiovascular and vascular disease. Corautus is currently developing and testing a gene therapy product using the Vascular... more

GlycoDesign is currently developing ATH in preclinical studies as a therapeutic for the prevention of neurocognitive deficits during cardiopulmonary bypass surgery. The Company plans to partner with device companies to develop ATH as an antithrombotic coating on catheters used for... more

ImmunoVaccine Technologies is a local biotechnology company located in downtown Halifax. We operate in a high-growth, fast-paced industry where innovation is the key to success. We are currently recruiting an Administrative Assistant who will be an assistant to the Office Manager. The... more

At Semafore we are dedicated to discovering and developing the next generation of novel cancer therapeutics. Semafore currently employs over 20 people and is headquartered in Indianapolis, Indiana --home of the famous Indy 500 and leading a growing life sciences environment in the State.... more

OncoGenex is a private biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company's three product candidates are designed to inhibit the production of specific proteins associated... more